Burke, R. T., Meadows, S., Loriaux, M. M., Currie, K. S., Mitchell, S. A., Maciejewski, P., . . . Spurgeon, S. E. (2014). A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor. Impact Journals LLC.
Stile di citazione ChicagoBurke, Russell T., et al. A Potential Therapeutic Strategy for Chronic Lymphocytic Leukemia By Combining Idelalisib and GS-9973, a Novel Spleen Tyrosine Kinase (Syk) Inhibitor. Impact Journals LLC, 2014.
Citazione MLABurke, Russell T., et al. A Potential Therapeutic Strategy for Chronic Lymphocytic Leukemia By Combining Idelalisib and GS-9973, a Novel Spleen Tyrosine Kinase (Syk) Inhibitor. Impact Journals LLC, 2014.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.